Login / Signup

Implications of Continuous Noninvasive Finger Cuff Arterial Pressure Device Use during Cesarean Delivery for Goal-Directed Fluid Therapy Preload Optimization: A Randomized Controlled Trial.

Shan-Han YangYi-Shiuan LinChien-Nan LeeYa-Jung ChengYing-Hsi ChenHsin-Chan ChiuChun-Yu Wu
Published in: BioMed research international (2021)
ClearSight-guided GDFT did not ameliorate postspinal hypotension but may reduce nausea. This trial is registered with NCT03013140.
Keyphrases
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • chemotherapy induced
  • stem cells
  • mesenchymal stem cells
  • cell therapy
  • open label
  • bone marrow